nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—CYP3A4—Rivastigmine—Alzheimer's disease	0.166	0.432	CbGbCtD
Solifenacin—CYP3A4—Donepezil—Alzheimer's disease	0.132	0.345	CbGbCtD
Solifenacin—CYP3A4—Galantamine—Alzheimer's disease	0.0853	0.223	CbGbCtD
Solifenacin—Delirium—Galantamine—Alzheimer's disease	0.00588	0.0127	CcSEcCtD
Solifenacin—Ileus—Donepezil—Alzheimer's disease	0.00554	0.012	CcSEcCtD
Solifenacin—Glaucoma—Donepezil—Alzheimer's disease	0.00521	0.0112	CcSEcCtD
Solifenacin—Intestinal obstruction—Rivastigmine—Alzheimer's disease	0.00511	0.011	CcSEcCtD
Solifenacin—Torsade de pointes—Memantine—Alzheimer's disease	0.00508	0.011	CcSEcCtD
Solifenacin—Ileus—Memantine—Alzheimer's disease	0.00503	0.0109	CcSEcCtD
Solifenacin—Cystitis noninfective—Galantamine—Alzheimer's disease	0.00494	0.0107	CcSEcCtD
Solifenacin—Cystitis—Galantamine—Alzheimer's disease	0.00488	0.0105	CcSEcCtD
Solifenacin—Glaucoma—Memantine—Alzheimer's disease	0.00473	0.0102	CcSEcCtD
Solifenacin—Glaucoma—Rivastigmine—Alzheimer's disease	0.00462	0.00999	CcSEcCtD
Solifenacin—Bladder pain—Galantamine—Alzheimer's disease	0.00457	0.00988	CcSEcCtD
Solifenacin—Benazepril—MTHFR—Alzheimer's disease	0.00429	0.463	CrCbGaD
Solifenacin—Dysphonia—Rivastigmine—Alzheimer's disease	0.00423	0.00914	CcSEcCtD
Solifenacin—Delirium—Memantine—Alzheimer's disease	0.00414	0.00894	CcSEcCtD
Solifenacin—Delirium—Rivastigmine—Alzheimer's disease	0.00405	0.00874	CcSEcCtD
Solifenacin—Gastrooesophageal reflux disease—Memantine—Alzheimer's disease	0.00394	0.00851	CcSEcCtD
Solifenacin—Atrial fibrillation—Galantamine—Alzheimer's disease	0.00387	0.00837	CcSEcCtD
Solifenacin—Renal impairment—Galantamine—Alzheimer's disease	0.00386	0.00833	CcSEcCtD
Solifenacin—Gastrooesophageal reflux disease—Rivastigmine—Alzheimer's disease	0.00385	0.00832	CcSEcCtD
Solifenacin—Cystitis noninfective—Donepezil—Alzheimer's disease	0.00383	0.00827	CcSEcCtD
Solifenacin—Cystitis—Donepezil—Alzheimer's disease	0.00379	0.00817	CcSEcCtD
Solifenacin—Dry eye—Donepezil—Alzheimer's disease	0.00362	0.00782	CcSEcCtD
Solifenacin—Bladder pain—Donepezil—Alzheimer's disease	0.00354	0.00765	CcSEcCtD
Solifenacin—Benazepril—ACE—Alzheimer's disease	0.0035	0.377	CrCbGaD
Solifenacin—Hyperkalaemia—Memantine—Alzheimer's disease	0.0035	0.00755	CcSEcCtD
Solifenacin—Urinary retention—Galantamine—Alzheimer's disease	0.00349	0.00754	CcSEcCtD
Solifenacin—Cystitis noninfective—Memantine—Alzheimer's disease	0.00348	0.00751	CcSEcCtD
Solifenacin—Cystitis—Memantine—Alzheimer's disease	0.00344	0.00742	CcSEcCtD
Solifenacin—Cystitis noninfective—Rivastigmine—Alzheimer's disease	0.0034	0.00734	CcSEcCtD
Solifenacin—Cystitis—Rivastigmine—Alzheimer's disease	0.00336	0.00726	CcSEcCtD
Solifenacin—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00335	0.00724	CcSEcCtD
Solifenacin—Muscular weakness—Galantamine—Alzheimer's disease	0.00324	0.00699	CcSEcCtD
Solifenacin—Bladder pain—Memantine—Alzheimer's disease	0.00322	0.00695	CcSEcCtD
Solifenacin—Bladder pain—Rivastigmine—Alzheimer's disease	0.00315	0.0068	CcSEcCtD
Solifenacin—Atrial fibrillation—Donepezil—Alzheimer's disease	0.003	0.00648	CcSEcCtD
Solifenacin—Depression—Galantamine—Alzheimer's disease	0.00282	0.00609	CcSEcCtD
Solifenacin—Renal failure—Galantamine—Alzheimer's disease	0.00278	0.00601	CcSEcCtD
Solifenacin—Urinary tract infection—Galantamine—Alzheimer's disease	0.00275	0.00594	CcSEcCtD
Solifenacin—Atrial fibrillation—Memantine—Alzheimer's disease	0.00273	0.00589	CcSEcCtD
Solifenacin—Renal impairment—Memantine—Alzheimer's disease	0.00271	0.00586	CcSEcCtD
Solifenacin—Urinary retention—Donepezil—Alzheimer's disease	0.00271	0.00584	CcSEcCtD
Solifenacin—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00268	0.00578	CcSEcCtD
Solifenacin—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.00267	0.00576	CcSEcCtD
Solifenacin—Renal impairment—Rivastigmine—Alzheimer's disease	0.00266	0.00574	CcSEcCtD
Solifenacin—Liver function test abnormal—Donepezil—Alzheimer's disease	0.00263	0.00567	CcSEcCtD
Solifenacin—Dry skin—Donepezil—Alzheimer's disease	0.00261	0.00563	CcSEcCtD
Solifenacin—Abdominal pain upper—Donepezil—Alzheimer's disease	0.0026	0.00561	CcSEcCtD
Solifenacin—Hallucination—Galantamine—Alzheimer's disease	0.00253	0.00546	CcSEcCtD
Solifenacin—Muscular weakness—Donepezil—Alzheimer's disease	0.00251	0.00542	CcSEcCtD
Solifenacin—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00251	0.00542	CcSEcCtD
Solifenacin—Oedema peripheral—Galantamine—Alzheimer's disease	0.0025	0.0054	CcSEcCtD
Solifenacin—Connective tissue disorder—Galantamine—Alzheimer's disease	0.0025	0.00539	CcSEcCtD
Solifenacin—Urethral disorder—Galantamine—Alzheimer's disease	0.00249	0.00538	CcSEcCtD
Solifenacin—Influenza—Donepezil—Alzheimer's disease	0.00246	0.00531	CcSEcCtD
Solifenacin—Urinary retention—Memantine—Alzheimer's disease	0.00246	0.00531	CcSEcCtD
Solifenacin—Urinary retention—Rivastigmine—Alzheimer's disease	0.0024	0.00519	CcSEcCtD
Solifenacin—Liver function test abnormal—Memantine—Alzheimer's disease	0.00239	0.00515	CcSEcCtD
Solifenacin—Eye disorder—Galantamine—Alzheimer's disease	0.00237	0.00513	CcSEcCtD
Solifenacin—Dry skin—Memantine—Alzheimer's disease	0.00237	0.00511	CcSEcCtD
Solifenacin—Cardiac disorder—Galantamine—Alzheimer's disease	0.00236	0.00509	CcSEcCtD
Solifenacin—CHRM4—nervous system—Alzheimer's disease	0.00234	0.069	CbGeAlD
Solifenacin—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.00233	0.00504	CcSEcCtD
Solifenacin—Dry skin—Rivastigmine—Alzheimer's disease	0.00232	0.005	CcSEcCtD
Solifenacin—CHRM2—forebrain—Alzheimer's disease	0.00232	0.0682	CbGeAlD
Solifenacin—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.00231	0.00498	CcSEcCtD
Solifenacin—Angiopathy—Galantamine—Alzheimer's disease	0.0023	0.00498	CcSEcCtD
Solifenacin—Dysuria—Donepezil—Alzheimer's disease	0.0023	0.00497	CcSEcCtD
Solifenacin—Immune system disorder—Galantamine—Alzheimer's disease	0.00229	0.00495	CcSEcCtD
Solifenacin—Muscular weakness—Memantine—Alzheimer's disease	0.00228	0.00492	CcSEcCtD
Solifenacin—CHRM4—central nervous system—Alzheimer's disease	0.00226	0.0665	CbGeAlD
Solifenacin—Influenza—Memantine—Alzheimer's disease	0.00223	0.00482	CcSEcCtD
Solifenacin—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00223	0.00481	CcSEcCtD
Solifenacin—Mental disorder—Galantamine—Alzheimer's disease	0.00223	0.00481	CcSEcCtD
Solifenacin—Malnutrition—Galantamine—Alzheimer's disease	0.00221	0.00477	CcSEcCtD
Solifenacin—Infestation—Donepezil—Alzheimer's disease	0.00219	0.00474	CcSEcCtD
Solifenacin—Infestation NOS—Donepezil—Alzheimer's disease	0.00219	0.00474	CcSEcCtD
Solifenacin—Depression—Donepezil—Alzheimer's disease	0.00219	0.00472	CcSEcCtD
Solifenacin—Dysgeusia—Galantamine—Alzheimer's disease	0.00217	0.00468	CcSEcCtD
Solifenacin—Renal failure—Donepezil—Alzheimer's disease	0.00216	0.00465	CcSEcCtD
Solifenacin—Urinary tract infection—Donepezil—Alzheimer's disease	0.00213	0.0046	CcSEcCtD
Solifenacin—CHRM2—telencephalon—Alzheimer's disease	0.00213	0.0627	CbGeAlD
Solifenacin—CHRM1—forebrain—Alzheimer's disease	0.00211	0.0621	CbGeAlD
Solifenacin—Dysuria—Memantine—Alzheimer's disease	0.00209	0.00451	CcSEcCtD
Solifenacin—Vision blurred—Galantamine—Alzheimer's disease	0.00208	0.0045	CcSEcCtD
Solifenacin—Dysuria—Rivastigmine—Alzheimer's disease	0.00204	0.00441	CcSEcCtD
Solifenacin—Infestation NOS—Memantine—Alzheimer's disease	0.00199	0.0043	CcSEcCtD
Solifenacin—Infestation—Memantine—Alzheimer's disease	0.00199	0.0043	CcSEcCtD
Solifenacin—Depression—Memantine—Alzheimer's disease	0.00199	0.00429	CcSEcCtD
Solifenacin—Hallucination—Donepezil—Alzheimer's disease	0.00196	0.00423	CcSEcCtD
Solifenacin—Renal failure—Memantine—Alzheimer's disease	0.00196	0.00423	CcSEcCtD
Solifenacin—Palpitations—Galantamine—Alzheimer's disease	0.00195	0.00422	CcSEcCtD
Solifenacin—Pharyngitis—Donepezil—Alzheimer's disease	0.00195	0.00422	CcSEcCtD
Solifenacin—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00195	0.00421	CcSEcCtD
Solifenacin—Infestation—Rivastigmine—Alzheimer's disease	0.00195	0.00421	CcSEcCtD
Solifenacin—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00194	0.0042	CcSEcCtD
Solifenacin—Depression—Rivastigmine—Alzheimer's disease	0.00194	0.00419	CcSEcCtD
Solifenacin—Oedema peripheral—Donepezil—Alzheimer's disease	0.00194	0.00419	CcSEcCtD
Solifenacin—CHRM1—telencephalon—Alzheimer's disease	0.00194	0.0571	CbGeAlD
Solifenacin—Urinary tract infection—Memantine—Alzheimer's disease	0.00194	0.00418	CcSEcCtD
Solifenacin—Urethral disorder—Donepezil—Alzheimer's disease	0.00193	0.00417	CcSEcCtD
Solifenacin—Cough—Galantamine—Alzheimer's disease	0.00193	0.00417	CcSEcCtD
Solifenacin—Renal failure—Rivastigmine—Alzheimer's disease	0.00191	0.00413	CcSEcCtD
Solifenacin—Hypertension—Galantamine—Alzheimer's disease	0.00191	0.00412	CcSEcCtD
Solifenacin—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00189	0.00409	CcSEcCtD
Solifenacin—CHRM3—forebrain—Alzheimer's disease	0.00189	0.0556	CbGeAlD
Solifenacin—Hepatobiliary disease—Memantine—Alzheimer's disease	0.00188	0.00407	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00187	0.00404	CcSEcCtD
Solifenacin—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00184	0.00398	CcSEcCtD
Solifenacin—Dry mouth—Galantamine—Alzheimer's disease	0.00184	0.00398	CcSEcCtD
Solifenacin—CHRM5—nervous system—Alzheimer's disease	0.00183	0.054	CbGeAlD
Solifenacin—Confusional state—Galantamine—Alzheimer's disease	0.00182	0.00393	CcSEcCtD
Solifenacin—CHRM4—brain—Alzheimer's disease	0.00179	0.0528	CbGeAlD
Solifenacin—Hallucination—Memantine—Alzheimer's disease	0.00178	0.00384	CcSEcCtD
Solifenacin—Pharyngitis—Memantine—Alzheimer's disease	0.00177	0.00383	CcSEcCtD
Solifenacin—Nervous system disorder—Galantamine—Alzheimer's disease	0.00177	0.00382	CcSEcCtD
Solifenacin—Urinary tract disorder—Memantine—Alzheimer's disease	0.00177	0.00381	CcSEcCtD
Solifenacin—CHRM5—central nervous system—Alzheimer's disease	0.00176	0.0519	CbGeAlD
Solifenacin—Tachycardia—Galantamine—Alzheimer's disease	0.00176	0.0038	CcSEcCtD
Solifenacin—Oedema peripheral—Memantine—Alzheimer's disease	0.00176	0.0038	CcSEcCtD
Solifenacin—Connective tissue disorder—Memantine—Alzheimer's disease	0.00176	0.00379	CcSEcCtD
Solifenacin—Skin disorder—Galantamine—Alzheimer's disease	0.00175	0.00379	CcSEcCtD
Solifenacin—Urethral disorder—Memantine—Alzheimer's disease	0.00175	0.00378	CcSEcCtD
Solifenacin—Hallucination—Rivastigmine—Alzheimer's disease	0.00174	0.00376	CcSEcCtD
Solifenacin—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00174	0.00375	CcSEcCtD
Solifenacin—CHRM3—telencephalon—Alzheimer's disease	0.00173	0.0511	CbGeAlD
Solifenacin—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00173	0.00373	CcSEcCtD
Solifenacin—Mental disorder—Donepezil—Alzheimer's disease	0.00172	0.00372	CcSEcCtD
Solifenacin—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00172	0.00372	CcSEcCtD
Solifenacin—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00172	0.00371	CcSEcCtD
Solifenacin—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00171	0.0037	CcSEcCtD
Solifenacin—Malnutrition—Donepezil—Alzheimer's disease	0.00171	0.0037	CcSEcCtD
Solifenacin—Erythema multiforme—Memantine—Alzheimer's disease	0.00169	0.00365	CcSEcCtD
Solifenacin—Dysgeusia—Donepezil—Alzheimer's disease	0.00168	0.00362	CcSEcCtD
Solifenacin—Eye disorder—Memantine—Alzheimer's disease	0.00167	0.00361	CcSEcCtD
Solifenacin—Cardiac disorder—Memantine—Alzheimer's disease	0.00166	0.00358	CcSEcCtD
Solifenacin—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00165	0.00357	CcSEcCtD
Solifenacin—Eye disorder—Rivastigmine—Alzheimer's disease	0.00163	0.00353	CcSEcCtD
Solifenacin—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00162	0.0035	CcSEcCtD
Solifenacin—Angiopathy—Memantine—Alzheimer's disease	0.00162	0.0035	CcSEcCtD
Solifenacin—Vision blurred—Donepezil—Alzheimer's disease	0.00162	0.00349	CcSEcCtD
Solifenacin—Immune system disorder—Memantine—Alzheimer's disease	0.00161	0.00349	CcSEcCtD
Solifenacin—Mediastinal disorder—Memantine—Alzheimer's disease	0.00161	0.00348	CcSEcCtD
Solifenacin—Somnolence—Galantamine—Alzheimer's disease	0.0016	0.00346	CcSEcCtD
Solifenacin—Dyspepsia—Galantamine—Alzheimer's disease	0.00159	0.00343	CcSEcCtD
Solifenacin—Angiopathy—Rivastigmine—Alzheimer's disease	0.00159	0.00343	CcSEcCtD
Solifenacin—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00158	0.0034	CcSEcCtD
Solifenacin—Decreased appetite—Galantamine—Alzheimer's disease	0.00157	0.00339	CcSEcCtD
Solifenacin—Mental disorder—Memantine—Alzheimer's disease	0.00157	0.00338	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00156	0.00336	CcSEcCtD
Solifenacin—Malnutrition—Memantine—Alzheimer's disease	0.00156	0.00336	CcSEcCtD
Solifenacin—Fatigue—Galantamine—Alzheimer's disease	0.00156	0.00336	CcSEcCtD
Solifenacin—Constipation—Galantamine—Alzheimer's disease	0.00154	0.00333	CcSEcCtD
Solifenacin—Mental disorder—Rivastigmine—Alzheimer's disease	0.00153	0.00331	CcSEcCtD
Solifenacin—Dysgeusia—Memantine—Alzheimer's disease	0.00152	0.00329	CcSEcCtD
Solifenacin—Malnutrition—Rivastigmine—Alzheimer's disease	0.00152	0.00329	CcSEcCtD
Solifenacin—Cough—Donepezil—Alzheimer's disease	0.0015	0.00323	CcSEcCtD
Solifenacin—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00149	0.00322	CcSEcCtD
Solifenacin—Mequitazine—CYP2D6—Alzheimer's disease	0.00149	0.16	CrCbGaD
Solifenacin—Feeling abnormal—Galantamine—Alzheimer's disease	0.00149	0.00321	CcSEcCtD
Solifenacin—Hypertension—Donepezil—Alzheimer's disease	0.00148	0.00319	CcSEcCtD
Solifenacin—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00148	0.00319	CcSEcCtD
Solifenacin—Vision blurred—Memantine—Alzheimer's disease	0.00147	0.00317	CcSEcCtD
Solifenacin—Vision blurred—Rivastigmine—Alzheimer's disease	0.00143	0.0031	CcSEcCtD
Solifenacin—Dry mouth—Donepezil—Alzheimer's disease	0.00143	0.00308	CcSEcCtD
Solifenacin—Abdominal pain—Galantamine—Alzheimer's disease	0.00143	0.00308	CcSEcCtD
Solifenacin—Confusional state—Donepezil—Alzheimer's disease	0.00141	0.00305	CcSEcCtD
Solifenacin—CHRM5—brain—Alzheimer's disease	0.0014	0.0412	CbGeAlD
Solifenacin—Infection—Donepezil—Alzheimer's disease	0.00139	0.003	CcSEcCtD
Solifenacin—Palpitations—Memantine—Alzheimer's disease	0.00138	0.00297	CcSEcCtD
Solifenacin—Nervous system disorder—Donepezil—Alzheimer's disease	0.00137	0.00296	CcSEcCtD
Solifenacin—Cough—Memantine—Alzheimer's disease	0.00136	0.00293	CcSEcCtD
Solifenacin—Palpitations—Rivastigmine—Alzheimer's disease	0.00135	0.0029	CcSEcCtD
Solifenacin—Hypertension—Memantine—Alzheimer's disease	0.00134	0.0029	CcSEcCtD
Solifenacin—Hypersensitivity—Galantamine—Alzheimer's disease	0.00133	0.00287	CcSEcCtD
Solifenacin—Cough—Rivastigmine—Alzheimer's disease	0.00133	0.00287	CcSEcCtD
Solifenacin—Hypertension—Rivastigmine—Alzheimer's disease	0.00131	0.00284	CcSEcCtD
Solifenacin—Dry mouth—Memantine—Alzheimer's disease	0.0013	0.0028	CcSEcCtD
Solifenacin—Asthenia—Galantamine—Alzheimer's disease	0.00129	0.0028	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00129	0.00278	CcSEcCtD
Solifenacin—Confusional state—Memantine—Alzheimer's disease	0.00128	0.00276	CcSEcCtD
Solifenacin—Dry mouth—Rivastigmine—Alzheimer's disease	0.00127	0.00274	CcSEcCtD
Solifenacin—Infection—Memantine—Alzheimer's disease	0.00126	0.00272	CcSEcCtD
Solifenacin—CHRM2—nervous system—Alzheimer's disease	0.00126	0.037	CbGeAlD
Solifenacin—Confusional state—Rivastigmine—Alzheimer's disease	0.00125	0.0027	CcSEcCtD
Solifenacin—Nervous system disorder—Memantine—Alzheimer's disease	0.00125	0.00269	CcSEcCtD
Solifenacin—Somnolence—Donepezil—Alzheimer's disease	0.00124	0.00268	CcSEcCtD
Solifenacin—Tachycardia—Memantine—Alzheimer's disease	0.00124	0.00268	CcSEcCtD
Solifenacin—Infection—Rivastigmine—Alzheimer's disease	0.00123	0.00267	CcSEcCtD
Solifenacin—Skin disorder—Memantine—Alzheimer's disease	0.00123	0.00266	CcSEcCtD
Solifenacin—Dyspepsia—Donepezil—Alzheimer's disease	0.00123	0.00266	CcSEcCtD
Solifenacin—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00122	0.00263	CcSEcCtD
Solifenacin—Decreased appetite—Donepezil—Alzheimer's disease	0.00122	0.00263	CcSEcCtD
Solifenacin—Tachycardia—Rivastigmine—Alzheimer's disease	0.00121	0.00262	CcSEcCtD
Solifenacin—CHRM2—central nervous system—Alzheimer's disease	0.00121	0.0357	CbGeAlD
Solifenacin—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00121	0.00261	CcSEcCtD
Solifenacin—Skin disorder—Rivastigmine—Alzheimer's disease	0.00121	0.00261	CcSEcCtD
Solifenacin—Fatigue—Donepezil—Alzheimer's disease	0.00121	0.0026	CcSEcCtD
Solifenacin—Constipation—Donepezil—Alzheimer's disease	0.0012	0.00258	CcSEcCtD
Solifenacin—Dizziness—Galantamine—Alzheimer's disease	0.00119	0.00258	CcSEcCtD
Solifenacin—Feeling abnormal—Donepezil—Alzheimer's disease	0.00115	0.00249	CcSEcCtD
Solifenacin—Vomiting—Galantamine—Alzheimer's disease	0.00115	0.00248	CcSEcCtD
Solifenacin—CHRM1—nervous system—Alzheimer's disease	0.00114	0.0337	CbGeAlD
Solifenacin—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00114	0.00247	CcSEcCtD
Solifenacin—Rash—Galantamine—Alzheimer's disease	0.00114	0.00246	CcSEcCtD
Solifenacin—Dermatitis—Galantamine—Alzheimer's disease	0.00114	0.00245	CcSEcCtD
Solifenacin—Headache—Galantamine—Alzheimer's disease	0.00113	0.00244	CcSEcCtD
Solifenacin—Somnolence—Memantine—Alzheimer's disease	0.00113	0.00244	CcSEcCtD
Solifenacin—Dyspepsia—Memantine—Alzheimer's disease	0.00112	0.00241	CcSEcCtD
Solifenacin—Urticaria—Donepezil—Alzheimer's disease	0.00111	0.0024	CcSEcCtD
Solifenacin—Abdominal pain—Donepezil—Alzheimer's disease	0.00111	0.00239	CcSEcCtD
Solifenacin—Somnolence—Rivastigmine—Alzheimer's disease	0.0011	0.00238	CcSEcCtD
Solifenacin—Decreased appetite—Memantine—Alzheimer's disease	0.0011	0.00238	CcSEcCtD
Solifenacin—CHRM1—central nervous system—Alzheimer's disease	0.0011	0.0325	CbGeAlD
Solifenacin—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.0011	0.00237	CcSEcCtD
Solifenacin—Fatigue—Memantine—Alzheimer's disease	0.00109	0.00236	CcSEcCtD
Solifenacin—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00109	0.00236	CcSEcCtD
Solifenacin—Constipation—Memantine—Alzheimer's disease	0.00109	0.00234	CcSEcCtD
Solifenacin—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00108	0.00233	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00107	0.00232	CcSEcCtD
Solifenacin—Nausea—Galantamine—Alzheimer's disease	0.00107	0.00231	CcSEcCtD
Solifenacin—Fatigue—Rivastigmine—Alzheimer's disease	0.00107	0.00231	CcSEcCtD
Solifenacin—Constipation—Rivastigmine—Alzheimer's disease	0.00106	0.00229	CcSEcCtD
Solifenacin—Feeling abnormal—Memantine—Alzheimer's disease	0.00105	0.00226	CcSEcCtD
Solifenacin—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00104	0.00224	CcSEcCtD
Solifenacin—Hypersensitivity—Donepezil—Alzheimer's disease	0.00103	0.00223	CcSEcCtD
Solifenacin—CHRM3—nervous system—Alzheimer's disease	0.00102	0.0302	CbGeAlD
Solifenacin—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00102	0.00221	CcSEcCtD
Solifenacin—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00102	0.00219	CcSEcCtD
Solifenacin—Urticaria—Memantine—Alzheimer's disease	0.00101	0.00218	CcSEcCtD
Solifenacin—Abdominal pain—Memantine—Alzheimer's disease	0.001	0.00217	CcSEcCtD
Solifenacin—Asthenia—Donepezil—Alzheimer's disease	0.001	0.00217	CcSEcCtD
Solifenacin—Pruritus—Donepezil—Alzheimer's disease	0.000989	0.00214	CcSEcCtD
Solifenacin—Urticaria—Rivastigmine—Alzheimer's disease	0.000987	0.00213	CcSEcCtD
Solifenacin—CHRM3—central nervous system—Alzheimer's disease	0.000986	0.029	CbGeAlD
Solifenacin—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000982	0.00212	CcSEcCtD
Solifenacin—CHRM2—brain—Alzheimer's disease	0.000961	0.0283	CbGeAlD
Solifenacin—Hypersensitivity—Memantine—Alzheimer's disease	0.000936	0.00202	CcSEcCtD
Solifenacin—Dizziness—Donepezil—Alzheimer's disease	0.000925	0.002	CcSEcCtD
Solifenacin—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000915	0.00198	CcSEcCtD
Solifenacin—Asthenia—Memantine—Alzheimer's disease	0.000911	0.00197	CcSEcCtD
Solifenacin—Pruritus—Memantine—Alzheimer's disease	0.000898	0.00194	CcSEcCtD
Solifenacin—Asthenia—Rivastigmine—Alzheimer's disease	0.000891	0.00192	CcSEcCtD
Solifenacin—Vomiting—Donepezil—Alzheimer's disease	0.000889	0.00192	CcSEcCtD
Solifenacin—Rash—Donepezil—Alzheimer's disease	0.000882	0.0019	CcSEcCtD
Solifenacin—Dermatitis—Donepezil—Alzheimer's disease	0.000881	0.0019	CcSEcCtD
Solifenacin—Pruritus—Rivastigmine—Alzheimer's disease	0.000879	0.0019	CcSEcCtD
Solifenacin—Headache—Donepezil—Alzheimer's disease	0.000876	0.00189	CcSEcCtD
Solifenacin—CHRM1—brain—Alzheimer's disease	0.000875	0.0258	CbGeAlD
Solifenacin—Dizziness—Memantine—Alzheimer's disease	0.00084	0.00181	CcSEcCtD
Solifenacin—Nausea—Donepezil—Alzheimer's disease	0.000831	0.00179	CcSEcCtD
Solifenacin—Dizziness—Rivastigmine—Alzheimer's disease	0.000821	0.00177	CcSEcCtD
Solifenacin—Vomiting—Memantine—Alzheimer's disease	0.000807	0.00174	CcSEcCtD
Solifenacin—Rash—Memantine—Alzheimer's disease	0.000801	0.00173	CcSEcCtD
Solifenacin—Dermatitis—Memantine—Alzheimer's disease	0.0008	0.00173	CcSEcCtD
Solifenacin—Headache—Memantine—Alzheimer's disease	0.000796	0.00172	CcSEcCtD
Solifenacin—Vomiting—Rivastigmine—Alzheimer's disease	0.00079	0.00171	CcSEcCtD
Solifenacin—Rash—Rivastigmine—Alzheimer's disease	0.000783	0.00169	CcSEcCtD
Solifenacin—CHRM3—brain—Alzheimer's disease	0.000783	0.0231	CbGeAlD
Solifenacin—Dermatitis—Rivastigmine—Alzheimer's disease	0.000783	0.00169	CcSEcCtD
Solifenacin—Headache—Rivastigmine—Alzheimer's disease	0.000778	0.00168	CcSEcCtD
Solifenacin—Nausea—Memantine—Alzheimer's disease	0.000754	0.00163	CcSEcCtD
Solifenacin—Nausea—Rivastigmine—Alzheimer's disease	0.000738	0.00159	CcSEcCtD
Solifenacin—CYP3A4—nervous system—Alzheimer's disease	0.000563	0.0166	CbGeAlD
Solifenacin—CYP3A4—central nervous system—Alzheimer's disease	0.000542	0.016	CbGeAlD
Solifenacin—CHRM3—Signaling by GPCR—CCR5—Alzheimer's disease	3.72e-05	0.000337	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IGF1R—Alzheimer's disease	3.7e-05	0.000335	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.69e-05	0.000335	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	3.68e-05	0.000334	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IGF2—Alzheimer's disease	3.66e-05	0.000332	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	3.65e-05	0.000331	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HTR2A—Alzheimer's disease	3.64e-05	0.00033	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ABCA1—Alzheimer's disease	3.63e-05	0.000329	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	3.6e-05	0.000327	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NPS—Alzheimer's disease	3.58e-05	0.000325	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NPS—Alzheimer's disease	3.57e-05	0.000324	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.57e-05	0.000323	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	3.57e-05	0.000323	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PPP3CA—Alzheimer's disease	3.55e-05	0.000322	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—LPL—Alzheimer's disease	3.55e-05	0.000322	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IGF1R—Alzheimer's disease	3.54e-05	0.000321	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	3.54e-05	0.000321	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—F2—Alzheimer's disease	3.52e-05	0.000319	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	3.52e-05	0.000319	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MEF2C—Alzheimer's disease	3.51e-05	0.000319	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PTK2B—Alzheimer's disease	3.51e-05	0.000319	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—F2—Alzheimer's disease	3.51e-05	0.000318	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PTK2B—Alzheimer's disease	3.5e-05	0.000318	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	3.48e-05	0.000315	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	3.47e-05	0.000315	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PRKCG—Alzheimer's disease	3.45e-05	0.000313	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NTRK2—Alzheimer's disease	3.42e-05	0.00031	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GAB2—Alzheimer's disease	3.42e-05	0.00031	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SST—Alzheimer's disease	3.42e-05	0.00031	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GAB2—Alzheimer's disease	3.41e-05	0.000309	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SST—Alzheimer's disease	3.41e-05	0.000309	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NTRK2—Alzheimer's disease	3.41e-05	0.000309	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CALM1—Alzheimer's disease	3.4e-05	0.000309	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—LPL—Alzheimer's disease	3.4e-05	0.000308	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CALM1—Alzheimer's disease	3.39e-05	0.000308	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GSK3A—Alzheimer's disease	3.39e-05	0.000307	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GSK3A—Alzheimer's disease	3.38e-05	0.000306	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SST—Alzheimer's disease	3.37e-05	0.000306	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	3.37e-05	0.000306	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	3.37e-05	0.000306	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MEF2C—Alzheimer's disease	3.36e-05	0.000305	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	3.36e-05	0.000305	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NGF—Alzheimer's disease	3.36e-05	0.000305	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	3.34e-05	0.000303	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APP—Alzheimer's disease	3.33e-05	0.000302	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APP—Alzheimer's disease	3.32e-05	0.000301	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PRKCG—Alzheimer's disease	3.3e-05	0.000299	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APP—Alzheimer's disease	3.29e-05	0.000298	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCR5—Alzheimer's disease	3.27e-05	0.000296	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NGF—Alzheimer's disease	3.22e-05	0.000292	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	3.2e-05	0.00029	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HTR2A—Alzheimer's disease	3.2e-05	0.00029	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—F2—Alzheimer's disease	3.19e-05	0.000289	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	3.16e-05	0.000286	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	3.14e-05	0.000285	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PLCB1—Alzheimer's disease	3.13e-05	0.000284	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PPARGC1A—Alzheimer's disease	3.13e-05	0.000284	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCR5—Alzheimer's disease	3.13e-05	0.000284	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—HMOX1—Alzheimer's disease	3.12e-05	0.000283	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	3.1e-05	0.000281	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HTR2A—Alzheimer's disease	3.06e-05	0.000278	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CALM1—Alzheimer's disease	2.98e-05	0.00027	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—LEP—Alzheimer's disease	2.97e-05	0.00027	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—APOE—Alzheimer's disease	2.97e-05	0.00027	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CAV1—Alzheimer's disease	2.94e-05	0.000267	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	2.93e-05	0.000266	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NGFR—Alzheimer's disease	2.92e-05	0.000265	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	2.91e-05	0.000264	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CREB1—Alzheimer's disease	2.9e-05	0.000263	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	2.89e-05	0.000263	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	2.88e-05	0.000261	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	2.86e-05	0.00026	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CALM1—Alzheimer's disease	2.86e-05	0.000259	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ADAM10—Alzheimer's disease	2.86e-05	0.000259	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	2.85e-05	0.000259	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—LPL—Alzheimer's disease	2.85e-05	0.000258	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—APOE—Alzheimer's disease	2.85e-05	0.000258	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—LEP—Alzheimer's disease	2.85e-05	0.000258	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CCL2—Alzheimer's disease	2.84e-05	0.000258	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—ESR1—Alzheimer's disease	2.84e-05	0.000257	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	2.83e-05	0.000256	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CAV1—Alzheimer's disease	2.82e-05	0.000256	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	2.81e-05	0.000255	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—F2—Alzheimer's disease	2.8e-05	0.000254	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NOTCH1—Alzheimer's disease	2.74e-05	0.000249	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ESR1—Alzheimer's disease	2.72e-05	0.000246	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	2.71e-05	0.000246	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—S100B—Alzheimer's disease	2.7e-05	0.000245	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—F2—Alzheimer's disease	2.68e-05	0.000243	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	2.67e-05	0.000242	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NOTCH1—Alzheimer's disease	2.63e-05	0.000238	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	2.58e-05	0.000234	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—GSK3B—Alzheimer's disease	2.57e-05	0.000233	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IGF2—Alzheimer's disease	2.57e-05	0.000233	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—MTHFR—Alzheimer's disease	2.57e-05	0.000233	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CREB1—Alzheimer's disease	2.55e-05	0.000232	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	2.55e-05	0.000231	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—INS—Alzheimer's disease	2.54e-05	0.00023	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCL2—Alzheimer's disease	2.5e-05	0.000227	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	2.49e-05	0.000226	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IGF1R—Alzheimer's disease	2.49e-05	0.000225	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—GSK3B—Alzheimer's disease	2.46e-05	0.000224	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	2.46e-05	0.000223	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IGF1—Alzheimer's disease	2.46e-05	0.000223	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CREB1—Alzheimer's disease	2.44e-05	0.000222	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—INS—Alzheimer's disease	2.43e-05	0.000221	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CALM1—Alzheimer's disease	2.4e-05	0.000217	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCL2—Alzheimer's disease	2.39e-05	0.000217	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	2.39e-05	0.000217	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—APOE—Alzheimer's disease	2.39e-05	0.000217	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—LPL—Alzheimer's disease	2.38e-05	0.000216	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	2.37e-05	0.000215	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CAV1—Alzheimer's disease	2.37e-05	0.000215	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MEF2C—Alzheimer's disease	2.36e-05	0.000214	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	2.36e-05	0.000214	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IGF1—Alzheimer's disease	2.35e-05	0.000213	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	2.34e-05	0.000212	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	2.32e-05	0.000211	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PRKCG—Alzheimer's disease	2.32e-05	0.00021	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.3e-05	0.000208	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.3e-05	0.000208	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	2.29e-05	0.000208	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	2.26e-05	0.000205	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NGF—Alzheimer's disease	2.26e-05	0.000205	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	2.23e-05	0.000203	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NOS3—Alzheimer's disease	2.23e-05	0.000202	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.2e-05	0.0002	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	2.2e-05	0.0002	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	2.2e-05	0.000199	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	2.17e-05	0.000197	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	2.16e-05	0.000195	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	2.15e-05	0.000195	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NOS3—Alzheimer's disease	2.13e-05	0.000193	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	2.13e-05	0.000193	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.12e-05	0.000192	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PPARG—Alzheimer's disease	2.08e-05	0.000189	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.05e-05	0.000186	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—INS—Alzheimer's disease	2.04e-05	0.000185	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	2.01e-05	0.000182	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	2e-05	0.000182	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	2e-05	0.000182	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	2e-05	0.000182	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	2e-05	0.000181	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	2e-05	0.000181	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	1.99e-05	0.00018	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	1.98e-05	0.00018	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	1.98e-05	0.000179	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	1.98e-05	0.000179	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	1.98e-05	0.000179	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	1.96e-05	0.000178	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	1.91e-05	0.000174	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—AKT1—Alzheimer's disease	1.91e-05	0.000173	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	1.91e-05	0.000173	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CASP3—Alzheimer's disease	1.89e-05	0.000171	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—F2—Alzheimer's disease	1.89e-05	0.000171	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	1.89e-05	0.000171	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—F2—Alzheimer's disease	1.88e-05	0.000171	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL6—Alzheimer's disease	1.88e-05	0.00017	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—F2—Alzheimer's disease	1.87e-05	0.000169	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.85e-05	0.000168	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	1.84e-05	0.000167	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—AKT1—Alzheimer's disease	1.83e-05	0.000166	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.83e-05	0.000166	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CASP3—Alzheimer's disease	1.81e-05	0.000164	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL6—Alzheimer's disease	1.8e-05	0.000163	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—NOS3—Alzheimer's disease	1.79e-05	0.000162	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.78e-05	0.000162	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.76e-05	0.00016	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MAPK8—Alzheimer's disease	1.74e-05	0.000158	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	1.74e-05	0.000157	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—AKT1—Alzheimer's disease	1.73e-05	0.000157	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	1.73e-05	0.000157	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	1.72e-05	0.000156	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	1.72e-05	0.000156	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	1.71e-05	0.000155	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—INS—Alzheimer's disease	1.71e-05	0.000155	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—INS—Alzheimer's disease	1.71e-05	0.000155	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	1.7e-05	0.000154	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—INS—Alzheimer's disease	1.69e-05	0.000153	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	1.68e-05	0.000153	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	1.68e-05	0.000152	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.67e-05	0.000151	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.67e-05	0.000151	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	1.66e-05	0.000151	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	1.66e-05	0.000151	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	1.66e-05	0.00015	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	1.66e-05	0.00015	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	1.65e-05	0.00015	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.64e-05	0.000149	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTGS2—Alzheimer's disease	1.64e-05	0.000148	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	1.63e-05	0.000148	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	1.6e-05	0.000145	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.55e-05	0.000141	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	1.54e-05	0.000139	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	1.5e-05	0.000136	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	1.5e-05	0.000136	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	1.48e-05	0.000134	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	1.47e-05	0.000134	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.46e-05	0.000133	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.42e-05	0.000129	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	1.41e-05	0.000128	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.29e-05	0.000117	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.28e-05	0.000116	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.27e-05	0.000116	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	1.27e-05	0.000115	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.27e-05	0.000115	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.27e-05	0.000115	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	1.26e-05	0.000114	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.26e-05	0.000114	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.25e-05	0.000113	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.22e-05	0.000111	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.22e-05	0.00011	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	1.21e-05	0.00011	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.17e-05	0.000106	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.17e-05	0.000106	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.17e-05	0.000106	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.16e-05	0.000106	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	1.16e-05	0.000105	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.16e-05	0.000105	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.15e-05	0.000105	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.11e-05	0.000101	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	1.11e-05	0.000101	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.08e-05	9.81e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	1.08e-05	9.78e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.07e-05	9.68e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	1.06e-05	9.64e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	1.02e-05	9.28e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1e-05	9.1e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	9.93e-06	9e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	9.89e-06	8.97e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	9.8e-06	8.89e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	9.8e-06	8.89e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CALM1—Alzheimer's disease	9.37e-06	8.5e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—APOE—Alzheimer's disease	9.34e-06	8.47e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CAV1—Alzheimer's disease	9.25e-06	8.39e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—AKT1—Alzheimer's disease	8.23e-06	7.46e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	8.17e-06	7.41e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	8.15e-06	7.39e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARG—Alzheimer's disease	8.13e-06	7.38e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	8.07e-06	7.32e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—INS—Alzheimer's disease	7.98e-06	7.24e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	7.48e-06	6.78e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	7.46e-06	6.76e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	7.38e-06	6.7e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7e-06	6.35e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	6.9e-06	6.26e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	6.88e-06	6.24e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	6.81e-06	6.18e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.4e-06	5.8e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.22e-06	2.92e-05	CbGpPWpGaD
